Product Categories
Country: | United States |
---|---|
Tel: | 781-+1-781-999-5354 |
Mobile: | +1-00000000000 |
E-mail: | info@targetmol.com |
QQ: | |
Skype: | Chat Now! |
Address: | 36 Washington Street, Wellesley Hills |
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
Product Name | MF | CAS | Details |
---|
BVT 2733 | C17H21ClN4O3S2 | 376640-41-4 | Details |
Palosuran;ACT-058362 | C25H30N4O2 | 540769-28-6 | Details |
Purvalanol A;NG-60 | C19H25ClN6O | 212844-53-6 | Details |
ELR510444;LR 510444;LR510444;LR-510444 | C19H16N2O2S2 | 1233948-35-0 | Details |
APY0201 | C23H23N7O | 1232221-74-7 | Details |
kb NB 142-70 | C11H9NO2S2 | 1233533-04-4 | Details |
Tyrphostin 23;RG-50810;TX 825;Tyrphostin A23;AG18 | C10H6N2O2 | 118409-57-7 | Details |
Semaxinib;SU5416 | C15H14N2O | 204005-46-9 | Details |
Bioymifi;DR5 Activator | C22H12BrN3O4S | 1420071-30-2 | Details |
Quizartinib;AC220 | C29H32N6O4S | 950769-58-1 | Details |
NS11394;NS 11394 | C23H19N3O | 951650-22-9 | Details |
LB-100 | C13H20N2O4 | 1026680-07-8 | Details |
TH287;TH287 hydrochloride | C11H10Cl2N4 | 1609960-30-6 | Details |
Agerafenib;CEP-32496;RXDX-105;CEP 32496;CEP32496 | C24H22F3N5O5 | 1188910-76-0 | Details |
MCOPPB triHydrochloride;MCOPPB trihydrochlride;MCOPPB 3HCl | C26H43Cl3N4 | 1108147-88-1 | Details |
BET bromodomain inhibitor | C24H20ClN5O2 | 1505453-59-7 | Details |
GSK2636771;GSK 2636771;GSK-2636771 | C22H22F3N3O3 | 1372540-25-4 | Details |
Raf inhibitor 1;B-Raf inhibitor 1 | C26H19ClN8 | 1093100-40-3 | Details |
Pyrazolo[1,5-a]pyrimidine 4h | C23H23N5O2 | 597544-21-3 | Details |
Pimavanserin;ACP-103 | C25H34FN3O2 | 706779-91-1 | Details |
Atorvastatin | C33H35FN2O5 | 134523-00-5 | Details |
Adavosertib;MK-1775;AZD1775;Adavosertib (MK-1775) | C27H32N8O2 | 955365-80-7 | Details |
Fimepinostat;CUDC-907;CUDC 907;PI3K/HDAC Inhibitor | C23H24N8O4S | 1339928-25-4 | Details |
GSK126;GSK2816126A;EZH2 inhibitor | C31H38N6O2 | 1346574-57-9 | Details |
Magnesium Lithospermate B;Monomethyl lithospermate B;Lithospermate B | C36H28MgO16 | 122021-74-3 | Details |
LCL161 | C26H33FN4O3S | 1005342-46-0 | Details |
LY2409881 trihydrochloride;LY2409881 | C24H30Cl2N6OS | 946518-60-1 | Details |
CDK4-IN-1 | C22H29ClN8 | 1256963-02-6 | Details |
PI-3065;PI3065 | C27H31FN6OS | 955977-50-1 | Details |
ETP-46464;ETP46464 | C30H22N4O2 | 1345675-02-6 | Details |
PQ401;IGF-1R Inhibitor II | C18H16ClN3O2 | 196868-63-0 | Details |
ELN-441958;ELN 441958 | C29H29ClN4O2 | 913064-47-8 | Details |
AF-353;Ro-4;AF 353 | C14H17IN4O2 | 865305-30-2 | Details |
APD668;APD 668 | C21H24FN5O5S | 832714-46-2 | Details |
Eniporide | C14H16N4O3S | 176644-21-6 | Details |
Lexibulin;CYT-997 | C24H30N6O2 | 917111-44-5 | Details |
Amitifadine hydrochloride;DOV-21947 hydrochloride;EB-1010 hydrochloride | C11H12Cl3N | 410074-74-7 | Details |
PF 03716556;PF-3716556 | C22H26N4O3 | 928774-43-0 | Details |
Danusertib;PHA-739358 | C26H30N6O3 | 827318-97-8 | Details |
Seliciclib;Roscovitine;R-roscovitine;CYC202 | C19H26N6O | 186692-46-6 | Details |
Framycetin sulfate;Framycetin sulphate;Neomycin Sulphate B | C23H48N6O17S | 4146-30-9 | Details |
C-7280948;C7280948 | C14H16N2O2S | 587850-67-7 | Details |
A 77-01;A77-01 | C18H14N4 | 607737-87-1 | Details |
ABT-737;ABT737;ABT 737 | C42H45ClN6O5S2 | 852808-04-9 | Details |
CX-5461;CX5461 | C27H27N7O2S | 1138549-36-6 | Details |
Navitoclax;ABT-263 | C47H55ClF3N5O6S3 | 923564-51-6 | Details |
FH1;BRD-K4477;NSC 12407 | C17H18N2O2 | 2719-05-3 | Details |
Ispinesib;CK0238273;SB-715992 | C30H33ClN4O2 | 336113-53-2 | Details |
AGI-5198;IDH-C35;AGI5198;AGI 5198 | C27H31FN4O2 | 1355326-35-0 | Details |
Veliparib dihydrochloride;ABT-888 dihydrochloride | C13H16N4O | 912445-05-7 | Details |
WS6 | C29H31F3N6O3 | 1421227-53-3 | Details |
SD-208;SD208;SD 208;ALK5 Inhibitor V | C17H10ClFN6 | 627536-09-8 | Details |
(+)-JQ-1;JQ1 | C23H25ClN4O2S | 1268524-70-4 | Details |
Sepantronium bromide;YM155 | C20H19BrN4O3 | 781661-94-7 | Details |
Fexinidazole;HOE 239 | C12H13N3O3S | 59729-37-2 | Details |
PHA-793887;PHA 793887;PHA793887 | C19H31N5O2 | 718630-59-2 | Details |
VER-82576;NVP-BEP800 | C21H23Cl2N5O2S | 847559-80-2 | Details |
Pexidartinib;PLX-3397 | C20H15ClF3N5 | 1029044-16-3 | Details |
AEE788;NVP-AEE 788 | C27H32N6 | 497839-62-0 | Details |
PSI-6206;GS-331007;PSI6206;2'-deoxy-2'-fluoro-2'-C-methyluridine;RO 2433 | C10H13FN2O5 | 863329-66-2 | Details |
SC-514;GK 01140;SC514;SC 514 | C9H8N2OS2 | 354812-17-2 | Details |
Venetoclax;ABT 199;ABT199;GDC-0199;ABT-199 | C45H50ClN7O7S | 1257044-40-8 | Details |
I-BET151;GSK1210151A | C23H21N5O3 | 1300031-49-5 | Details |
SW033291 | C21H20N2OS3 | 459147-39-8 | Details |
Ixazomib;MLN2238 | C14H19BCl2N2O4 | 1072833-77-2 | Details |
LY2109761 | C26H27N5O2 | 700874-71-1 | Details |
PJ34 hydrochloride;PJ34 HCl | C17H17N3O2HCl | 344458-15-7 | Details |
Trametinib;JTP-74057;GSK1120212 | C26H23FIN5O4 | 871700-17-3 | Details |
OF-1;OF 1;OF1 | C17H18BrN3O4S | 919973-83-4 | Details |
SBI-0206965;SBI 0206965;SBI0206965 | C21H21BrN4O5 | 1884220-36-3 | Details |
Propidium Iodide;PI | C27H34IN4+ | 25535-16-4 | Details |
Articaine hydrochloride;Ultracaine;Hoe-045;Articaine HCl | C13H20N2O3S.ClH | 23964-57-0 | Details |
Afatinib;Afatinib free base;BIBW 2992 | C24H25ClFN5O3 | 850140-72-6 | Details |
Buspirone hydrochloride;Buspirone HCl;Narol;Buspar | C21H32ClN5O2 | 33386-08-2 | Details |
Adenosine monophosphate;5'-Adenylic acid;Adenosine 5'-monophosphate;AMP | C10H14N5O7P | 61-19-8 | Details |
Dorzolamide hydrochloride;Dorzolamide HCl;MK507 hydrochloride;L671152 hydrochloride;MK-507 (L-671152) HCl | C10H17ClN2O4S3 | 130693-82-2 | Details |
Geniposidic Acid | C16H22O10 | 27741-01-1 | Details |
Ibudilast;KC-404;MN-166;AV-411 | C14H18N2O | 50847-11-5 | Details |
Parthenolide;(-)-Parthenolide | C15H20O3 | 20554-84-1 | Details |
Mecamylamine hydrochloride;Mevasin;Inversine | C11H22ClN | 826-39-1 | Details |
Yohimbine hydrochloride;Yohimbine HCl;Antagonil | C21H27ClN2O3 | 65-19-0 | Details |
Bergapten;5-Methoxypsoralen | C12H8O4 | 484-20-8 | Details |
Tacrolimus;FR900506;Fujimycin;FK506 | C44H69NO12 | 104987-11-3 | Details |
Temsirolimus;NSC 683864;CCI-779 | C56H87NO16 | 162635-04-3 | Details |
Fulvestrant;ZM 182780;ZD 9238;ICI 182780 | C32H47F5O3S | 129453-61-8 | Details |
Carbidopa monohydrate;S(-)-Carbidopa;Carbidopa Hydrate | C10H16N2O5 | 38821-49-7 | Details |
Vinburnine;L-Eburnamonine;(-)-Eburnamonine;(-)-Vincamone;Vincamone;Eburnalritardo | C19H22N2O | 4880-88-0 | Details |
Guanfacine hydrochloride;Tenex;Intuniv;Guanfacine | C9H10Cl3N3O | 29110-48-3 | Details |
Methyl carbamate;Methylurethan;Urethylane | C2H5NO2 | 598-55-0 | Details |
Dibutyl carbonate | C9H18O3 | 542-52-9 | Details |
4-amino-1,8-Naphthalimide | C12H8N2O2 | 1742-95-6 | Details |
1-NM-PP1;PP1 Analog II;1 nM-PP1 | C20H21N5 | 221244-14-0 | Details |
MG-132;Z-Leu-Leu-Leu-CHO;MG132;MG 132;Z-LLL-al | C26H41N3O5 | 133407-82-6 | Details |
Thiazovivin | C15H13N5OS | 1226056-71-8 | Details |
M344;Histone Deacetylase Inhibitor III;MS 344 | C16H25N3O3 | 251456-60-7 | Details |
CaMKP Inhibitor | C10H8NNaO7S2 | 52789-62-5 | Details |
Suramin Sodium Salt;Suramin hexasodium salt;NF-060;BAY-205 | C51H34N6Na6O23S6 | 129-46-4 | Details |
Cardiogenol C | C13H16N4O2 | 671225-39-1 | Details |
Nutlin-3;Nutlin 3;Nutlin3 | C30H30Cl2N4O4 | 548472-68-0 | Details |
WP1066 | C17H14BrN3O | 857064-38-1 | Details |
Product Total: Product Page: | ||||
84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 |